Cargando…

Association of Differing Qatari Genotypes with Vitamin D Metabolites

OBJECTIVE: Genetic studies have identified four Qatari genotypes: Q1 Arab, Bedouin; Q2 Asian/Persian; Q3 African; and a fourth admixed group not fitting into the previous 3 groups. This study was undertaken to determine if there was an increased risk of deficiency of vitamin D and its metabolites as...

Descripción completa

Detalles Bibliográficos
Autores principales: Dakroury, Youssra, Butler, Alexandra E., Dargham, Soha R., Latif, Aishah, Robay, Amal, Crystal, Ronald G., Atkin, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174927/
https://www.ncbi.nlm.nih.gov/pubmed/32351562
http://dx.doi.org/10.1155/2020/7831590
_version_ 1783524725544189952
author Dakroury, Youssra
Butler, Alexandra E.
Dargham, Soha R.
Latif, Aishah
Robay, Amal
Crystal, Ronald G.
Atkin, Stephen L.
author_facet Dakroury, Youssra
Butler, Alexandra E.
Dargham, Soha R.
Latif, Aishah
Robay, Amal
Crystal, Ronald G.
Atkin, Stephen L.
author_sort Dakroury, Youssra
collection PubMed
description OBJECTIVE: Genetic studies have identified four Qatari genotypes: Q1 Arab, Bedouin; Q2 Asian/Persian; Q3 African; and a fourth admixed group not fitting into the previous 3 groups. This study was undertaken to determine if there was an increased risk of deficiency of vitamin D and its metabolites associated with differing genotypes, perhaps due to genetic differences in skin pigmentation. METHODS: 398 Qatari subjects (220 type 2 diabetes and 178 controls) had their genotype determined by Affymetrix 500 k SNP arrays. Total values of 1,25-dihydroxyvitamin D (1,25(OH)2D), 25-hydroxyvitamin D (25(OH)D), 24,25-dihydroxyvitamin D (24,25(OH)2D), and 25-hydroxy-3epi-vitamin D (3epi-25(OH)D) concentrations were measured by the LC-MS/MS analysis. RESULTS: The distribution was as follows: 164 (41.2%) genotyped Q1, 149 (37.4%) genotyped Q2, 31 (7.8%) genotyped Q3, and 54 (13.6%) genotyped “admixed.” Median levels of 25(OH)D and 3epi-25(OH)D did not differ across Q1, Q2, Q3, and “admixed” genotypes, respectively. 1,25(OH)2D levels were lower (p < 0.04) between Q2 and the admixed groups, and 24,25(OH)2D levels were lower (p < 0.05) between Q1 and the admixed groups. Vitamin D metabolite levels were lower in females for 25(OH)D, 1,25(OH)2D (p < 0.001), and 24,25(OH)2D (p < 0.006), but 3epi-25(OH)D did not differ (p < 0.26). Diabetes prevalence was not different between genotypes. Total 1,25(OH)2D (p < 0.001), total 24,25(OH)2D (p < 0.001), and total 3epi-25(OH)D (p < 0.005) were all significantly lower in diabetes patients compared to controls whilst the total 25(OH)D was higher in diabetes than controls (p < 0.001). CONCLUSION: Whilst 25(OH)D levels did not differ between genotype groups, 1,25(OH)2D and 24,25(OH)2D were lower in the admixed group, suggesting that there are genetic differences in vitamin D metabolism that may be of importance in a population that may allow a more targeted approach to vitamin D replacement. This may be of specific importance in vitamin D replacement strategies with the Q2 genotype requiring less, and the other genotypes requiring more to increase 1,25(OH)2D. Whilst overall the group was vitamin D deficient, total 25(OH)D was higher in diabetes, but 1,25(OH)2D, 24,25(OH)2D, and 3epi-25(OH)D were lower in diabetes that did not affect the relationship to genotype.
format Online
Article
Text
id pubmed-7174927
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71749272020-04-29 Association of Differing Qatari Genotypes with Vitamin D Metabolites Dakroury, Youssra Butler, Alexandra E. Dargham, Soha R. Latif, Aishah Robay, Amal Crystal, Ronald G. Atkin, Stephen L. Int J Endocrinol Research Article OBJECTIVE: Genetic studies have identified four Qatari genotypes: Q1 Arab, Bedouin; Q2 Asian/Persian; Q3 African; and a fourth admixed group not fitting into the previous 3 groups. This study was undertaken to determine if there was an increased risk of deficiency of vitamin D and its metabolites associated with differing genotypes, perhaps due to genetic differences in skin pigmentation. METHODS: 398 Qatari subjects (220 type 2 diabetes and 178 controls) had their genotype determined by Affymetrix 500 k SNP arrays. Total values of 1,25-dihydroxyvitamin D (1,25(OH)2D), 25-hydroxyvitamin D (25(OH)D), 24,25-dihydroxyvitamin D (24,25(OH)2D), and 25-hydroxy-3epi-vitamin D (3epi-25(OH)D) concentrations were measured by the LC-MS/MS analysis. RESULTS: The distribution was as follows: 164 (41.2%) genotyped Q1, 149 (37.4%) genotyped Q2, 31 (7.8%) genotyped Q3, and 54 (13.6%) genotyped “admixed.” Median levels of 25(OH)D and 3epi-25(OH)D did not differ across Q1, Q2, Q3, and “admixed” genotypes, respectively. 1,25(OH)2D levels were lower (p < 0.04) between Q2 and the admixed groups, and 24,25(OH)2D levels were lower (p < 0.05) between Q1 and the admixed groups. Vitamin D metabolite levels were lower in females for 25(OH)D, 1,25(OH)2D (p < 0.001), and 24,25(OH)2D (p < 0.006), but 3epi-25(OH)D did not differ (p < 0.26). Diabetes prevalence was not different between genotypes. Total 1,25(OH)2D (p < 0.001), total 24,25(OH)2D (p < 0.001), and total 3epi-25(OH)D (p < 0.005) were all significantly lower in diabetes patients compared to controls whilst the total 25(OH)D was higher in diabetes than controls (p < 0.001). CONCLUSION: Whilst 25(OH)D levels did not differ between genotype groups, 1,25(OH)2D and 24,25(OH)2D were lower in the admixed group, suggesting that there are genetic differences in vitamin D metabolism that may be of importance in a population that may allow a more targeted approach to vitamin D replacement. This may be of specific importance in vitamin D replacement strategies with the Q2 genotype requiring less, and the other genotypes requiring more to increase 1,25(OH)2D. Whilst overall the group was vitamin D deficient, total 25(OH)D was higher in diabetes, but 1,25(OH)2D, 24,25(OH)2D, and 3epi-25(OH)D were lower in diabetes that did not affect the relationship to genotype. Hindawi 2020-04-13 /pmc/articles/PMC7174927/ /pubmed/32351562 http://dx.doi.org/10.1155/2020/7831590 Text en Copyright © 2020 Youssra Dakroury et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dakroury, Youssra
Butler, Alexandra E.
Dargham, Soha R.
Latif, Aishah
Robay, Amal
Crystal, Ronald G.
Atkin, Stephen L.
Association of Differing Qatari Genotypes with Vitamin D Metabolites
title Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_full Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_fullStr Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_full_unstemmed Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_short Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_sort association of differing qatari genotypes with vitamin d metabolites
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174927/
https://www.ncbi.nlm.nih.gov/pubmed/32351562
http://dx.doi.org/10.1155/2020/7831590
work_keys_str_mv AT dakrouryyoussra associationofdifferingqatarigenotypeswithvitamindmetabolites
AT butleralexandrae associationofdifferingqatarigenotypeswithvitamindmetabolites
AT darghamsohar associationofdifferingqatarigenotypeswithvitamindmetabolites
AT latifaishah associationofdifferingqatarigenotypeswithvitamindmetabolites
AT robayamal associationofdifferingqatarigenotypeswithvitamindmetabolites
AT crystalronaldg associationofdifferingqatarigenotypeswithvitamindmetabolites
AT atkinstephenl associationofdifferingqatarigenotypeswithvitamindmetabolites